Quarterly report pursuant to Section 13 or 15(d)

Summary of Activity with NCM Included in Company's Consolidated Financial Statements (Detail)

v3.19.3
Summary of Activity with NCM Included in Company's Consolidated Financial Statements (Detail) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Schedule Of Equity Method Investments [Line Items]        
Receipt of common units due to annual common unit adjustment ("CUA")     $ 1,552  
Equity in earnings $ 15,139 $ 14,158 33,982 $ 29,208
NCM        
Schedule Of Equity Method Investments [Line Items]        
Beginning Balance     275,592  
Beginning Balance     (287,349)  
Equity in earnings 9,050 $ 6,830 14,062 $ 11,341
Ending Balance 272,756   272,756  
Ending Balance (276,985)   (276,985)  
Investment In NCM        
Schedule Of Equity Method Investments [Line Items]        
Beginning Balance     275,592  
Receipt of common units due to annual common unit adjustment ("CUA")     1,552  
Receipt of excess cash distributions     (16,126)  
Receipt of cash under tax receivable agreement     (2,324)  
Equity in earnings     14,062  
Ending Balance 272,756   272,756  
NCM Screen Advertising Advances        
Schedule Of Equity Method Investments [Line Items]        
Beginning Balance     (287,349)  
Receipt of common units due to annual common unit adjustment ("CUA")     (1,552)  
Ending Balance (276,985)   (276,985)  
NCM Screen Advertising Advances | NCM        
Schedule Of Equity Method Investments [Line Items]        
Receipt of common units due to annual common unit adjustment ("CUA") [1]     1,552  
Amortization of deferred revenue     11,916  
Distributions from NCM        
Schedule Of Equity Method Investments [Line Items]        
Receipt of excess cash distributions     (8,009)  
Receipt of cash under tax receivable agreement     (1,159)  
Ending Balance (9,168)   (9,168)  
Equity in Earnings        
Schedule Of Equity Method Investments [Line Items]        
Ending Balance (14,062)   (14,062)  
Equity in Earnings | NCM        
Schedule Of Equity Method Investments [Line Items]        
Equity in earnings     (14,062)  
Other Revenues        
Schedule Of Equity Method Investments [Line Items]        
Revenues earned under ESA [2],[3]     (22,151)  
Revenues earned under amendment to ESA [3],[4]     (1,482)  
Total Revenues (35,549)   (35,549)  
Other Revenues | NCM        
Schedule Of Equity Method Investments [Line Items]        
Amortization of deferred revenue     (11,916)  
Interest Expense - NCM        
Schedule Of Equity Method Investments [Line Items]        
Revenues earned under ESA [2],[3]     13,392  
Revenues earned under amendment to ESA [3],[4]     788  
Ending Balance [3] 14,180   14,180  
Cash Received (Paid)        
Schedule Of Equity Method Investments [Line Items]        
Revenues earned under ESA [2],[3]     8,759  
Revenues earned under amendment to ESA [3],[4]     694  
Receipt of excess cash distributions     24,135  
Receipt of cash under tax receivable agreement     3,483  
Total Cash Received $ 37,071   $ 37,071  
[1] See Note 8 for the maturity of balance as of September 30, 2019.
[2] Amount includes the per patron and per digital screen theatre access fees due to the Company prior to the first amendment to the Amended and Restated ESA, net of amounts paid to NCM for on-screen advertising time provided to the Company’s beverage concessionaire of approximately $8,808.
[3] Reflects impact of significant financing component related to amounts received in advance under the ESA and CUA agreements.  See also Notes 3 and 4.
[4] Reflects screen rental revenues earned after the amendment to the ESA.